Xuelin (Steve) Wang
Lawyers
Filters
Ascentage Pharma $200 million at-the-market offering
We advised the sales agents on the offering
GenFleet Therapeutics HK$471.8 million placement of new H shares
We advised GenFleet Therapeutics on the placement
Alebund Pharmaceuticals HK$1.28 billion IPO
We advised Alebund Pharmaceuticals on its IPO and HKEX listing
CARsgen HK$470 million placement of shares and top-up subscription
We advised CARsgen on the placement and top-up subscription
METiS TechBio HK$2.43 billion IPO
We advised METiS TechBio on its IPO and HKEX listing
Mabwell Bioscience HK$1.2 billion IPO
We advised Mabwell on its IPO and HKEX listing
Adagene $70 million registered direct offering
We advised Adagene on the offering
Ascletis Pharma HK$843.5 million placement of shares
We advised the placing agent on the transaction
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
PegBio HK$300 million placement of shares
We advised PegBio on the placement of new shares